FindTrial
Sign In

Endoscopic Transconjunctival Transorbital Deep Lateral Wall Decompression for Thyroid-Associated Ophthalmopathy: an Innovative and Minimally Invasive Surgery without Temporal Hollowing and Oscillopsia

Endoscopic Transconjunctival Transorbital Deep Lateral Wall Decompression for Thyroid-Associated Ophthalmopathy: an Innovative and Minimally Invasive Surgery without Temporal Hollowing and Oscillopsia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041159
Enrollment
Unknown
Registered
2020-12-19
Start date
2019-03-01
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid-Associated Ophthalmopathy

Interventions

experimental group:Endoscopic transconjunctival transorbital deep lateral wall decompression

Sponsors

Wenzhou Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with TAO according to battle's diagnostic criteria; 2. Exophthalmos seriously affects the appearance; 3. The patient developed exposure keratitis.

Exclusion criteria

Exclusion criteria: 1. Ocular deviation caused by extraocular muscle lesions; 2. Patients with thyroid associated ophthalmopathy and optic neuropathy; 3. Patients who can't receive a second operation; 4. Patients with general anesthesia intolerance.

Design outcomes

Primary

MeasureTime frame
Exophthalmometry;—

Countries

China

Contacts

Public ContactTu Yunhai

Wenzhou Eye Hospital

23200469@qq.com+86 13857719061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026